Milestone Pharmaceuticals is trading at $0.74, up 5.32%, in pre-market; no company-specific announcement explaining the October 19 move was found.
- The latest highlighted trial update was October 9.
- U.S. futures were higher early Monday: Nasdaq futures rose 1.1% and S&P 500 futures rose 0.5%. This may reflect broader risk-on sentiment, but reporting does not establish a direct link to the stock’s move.
- Trading volume or activity level was not available in the provided price context or sources.